Roles of Gastric Non‐ Helicobacter pylori Helicobacter Species in Gastric Disease Development: A Review
Helicobacter · 2025
DOI: 10.1111/hel.70051 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Helicobacter, 2025. Verfasst von Mitsushige Sugimoto und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Genome-Wide Infectious Microbiology, Research Center for GLOBAL and LOCAL Infectious Disease, Oita University, Yufu, Oita, Japan. Hauptthemen laut MEDLINE: Helicobacter Infections, Helicobacter, Stomach Diseases. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 87 Literaturangaben. Gefördert von: JSPS KAKENHI.
Abstract (Originalsprache)
Gastric Helicobacter species, including Helicobacter pylori and non‐ Helicobacter pylori Helicobacter (NHPH) species, are gram‐negative fastidious bacteria that colonize the stomachs of both humans and animals such as pigs, dogs, cats, and monkeys. The H. pylori infection rate is decreasing due to improved living conditions and increased opportunities for H. pylori eradication therapy in developed countries. However, concerns about NHPH infection‐induced gastric diseases are growing, especially low‐grade gastric mucosa‐associated lymphoid tissue lymphoma. Although NHPH infections have been reported for 30 years, especially H. suis infections, evidence of the correct infection rate, route of infection to humans, and direct and indirect associations with gastric diseases are insufficient. Presently, NHPH infection can be diagnosed using histopathological and immunohistochemical findings, polymerase chain reaction, culture tests, or enzyme‐linked immunosorbent assays. Several basic and clinical studies have begun to report the bacteriologic characteristics and routes of NHPH infection. In addition, the high effectiveness of eradication therapy using a combination of an acid inhibitor and two types of antibiotics, which is the same eradication regimen for H. pylori infection, has been reported. However, evidence on antibiotic resistance, appropriate dosing dosage, or drug type provided by randomized control trials is lacking. Several issues regarding the etiology, virulence, diagnosis, and treatment of NHPH infections should be addressed in the future.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Genome-Wide Infectious Microbiology, Research Center for GLOBAL and LOCAL Infectious Disease, Oita University, Yufu, Oita, Japan.
- Department of Bacteriology II, National Institute of Infectious Diseases, Tokyo, Japan.
- Department of Gastroenterology, National Hospital Organization Kyoto Medical Center, Kyoto, Japan.
- Department of Environmental and Preventive Medicine, Oita University, Yufu, Oita, Japan.
- Department of Medicine, Gastroenterology and Hepatology Section, Baylor College of Medicine, Houston, Texas, USA.
ORCID-Profile: Mitsushige Sugimoto
Förderung
- JSPS KAKENHI
Zitieren
APA
Sugimoto, M., Rimbara, E., Murata, M., & Yamaoka, Y. (2025). Roles of Gastric Non‐ Helicobacter pylori Helicobacter Species in Gastric Disease Development: A Review. Helicobacter. https://doi.org/10.1111/hel.70051
Vancouver
Sugimoto M, Rimbara E, Murata M, Yamaoka Y. Roles of Gastric Non‐ Helicobacter pylori Helicobacter Species in Gastric Disease Development: A Review. Helicobacter. 2025. doi:10.1111/hel.70051
BibTeX
@article{Sugimoto2025,
author = {Sugimoto, Mitsushige and Rimbara, Emiko and Murata, Masaki and Yamaoka, Yoshio},
title = {Roles of Gastric Non‐ Helicobacter pylori Helicobacter Species in Gastric Disease Development: A Review},
journal = {Helicobacter},
year = {2025},
doi = {10.1111/hel.70051}
}
EUVIMED